Trial Profile
Treatment of Congenital Vascular Malformations Using Sirolimus: Improving Quality of Life
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 07 Mar 2023
Price :
$35
*
At a glance
- Drugs Sirolimus (Primary)
- Indications Vascular malformations
- Focus Therapeutic Use
- Acronyms Sirolimus
- 26 Nov 2021 Status changed from active, no longer recruiting to completed.
- 18 May 2021 Results (n=12) assessing the efficacy and safety of low dose sirolimus on low-flow vascular malformations, published in the Advances in Therapy.
- 28 Jan 2021 Status changed from recruiting to active, no longer recruiting.